Skip to content

13G/A filed by BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 1,690,014 VTGN shares, 3.7% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:25:41 UTC.

Accession
0000921895-26-003193
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

Stake

Shares
1,690,014
Percent of class
3.7%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group BVF INC/IL.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
BIOTECHNOLOGY VALUE FUND L PPN0870,9430870,943870,9431.9%
BVF I GP LLCOO0870,9430870,943870,9431.9%
BIOTECHNOLOGY VALUE FUND II LPPN0706,6920706,692706,6921.6%
BVF II GP LLCOO0706,6920706,692706,6921.6%
Biotechnology Value Trading Fund OS LPPN086,906086,90686,9060.2%
BVF Partners OS Ltd.CO086,906086,90686,9060.2%
BVF GP HOLDINGS LLCOO01,577,63501,577,6351,577,6353.4%
BVF PARTNERS L P/ILIA,PN01,690,01401,690,0141,690,0143.7%
BVF INC/ILCO01,690,01401,690,0141,690,0143.7%
LAMPERT MARK NIN01,690,01401,690,0141,690,0143.7%